11-35171082-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000610.4(CD44):c.68-5493C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.557 in 152,048 control chromosomes in the GnomAD database, including 24,487 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.56 ( 24487 hom., cov: 33)
Consequence
CD44
NM_000610.4 intron
NM_000610.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.163
Publications
7 publications found
Genes affected
CD44 (HGNC:1681): (CD44 molecule (IN blood group)) The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.691 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.557 AC: 84564AN: 151930Hom.: 24435 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
84564
AN:
151930
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.557 AC: 84686AN: 152048Hom.: 24487 Cov.: 33 AF XY: 0.554 AC XY: 41180AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
84686
AN:
152048
Hom.:
Cov.:
33
AF XY:
AC XY:
41180
AN XY:
74362
show subpopulations
African (AFR)
AF:
AC:
28921
AN:
41462
American (AMR)
AF:
AC:
8985
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1791
AN:
3466
East Asian (EAS)
AF:
AC:
1591
AN:
5174
South Asian (SAS)
AF:
AC:
2592
AN:
4818
European-Finnish (FIN)
AF:
AC:
4647
AN:
10566
Middle Eastern (MID)
AF:
AC:
166
AN:
294
European-Non Finnish (NFE)
AF:
AC:
34324
AN:
67958
Other (OTH)
AF:
AC:
1200
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1896
3791
5687
7582
9478
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1616
AN:
3478
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Calcium oxalate urolithiasis Other:1
Mar 01, 2014
Division of Molecular Genetics and Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University
Significance:association
Review Status:no assertion criteria provided
Collection Method:case-control
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.